# Prognosis of Postoperative Cholangitis Following Pancreaticoduodenectomy: A Single-Centered Retrospective Cohort Study

**Authors:** Shuhei Yamamoto, Yuki Kataoka, Hanako Kurai, Teiichi Sugiura, Yosuke Yamamoto

PMC · DOI: 10.7759/cureus.60392 · 2024-05-15

## TL;DR

This study finds that bile duct lesions after a specific surgery are linked to a higher risk of treatment failure for postoperative cholangitis.

## Contribution

The study identifies bile duct lesions as a significant predictor of treatment failure in postoperative cholangitis patients.

## Key findings

- 120 out of 154 admissions had bile duct lesions.
- Bile duct lesions were associated with treatment failure (adjusted OR 2.81).

## Abstract

Introduction

Postoperative cholangitis (POC) after pancreaticoduodenectomy is a serious complication. However, the prognostic factors are unclear. We aimed to investigate the relationships between biliary lesions and prognosis in patients with cholangitis after pancreaticoduodenectomy.

Methods

We conducted a single-centered retrospective cohort study. The unit of analysis was hospital admissions. We extracted patients who underwent pancreaticoduodenectomy from 2010 to 2018, and have a record of hospitalization of cholangitis from January 2010 to October 2019. We defined the bile duct lesions as the presence of one of the following: biliary stent, intrahepatic bile duct dilatation, intrahepatic bile duct stones, or common bile duct stones on imaging studies. The primary outcome was the treatment failure of POC. We defined the failure as a composite outcome of death within 30 days of initiation of treatment, relapse during treatment, or recurrence of cholangitis. We used logistic regression analysis to examine the association between the presence of bile duct lesions and the occurrence of outcomes.

Results

Of 154 admissions included in the present study, 120 cases (77.9%) were with bile duct lesions. Bile duct lesions were associated with the treatment failure (crude odds ratio [OR] 2.56, 95% confidence intervals [CI] 1.08 to 6.32; adjusted OR 2.81, 95%CI 1.08 to 7.34).

Conclusions

Clinicians should follow the patient of POC with bile duct lesions on imaging carefully because of the high risk of treatment failure, especially for recurrence. Further studies are warranted to confirm our results.

## Linked entities

- **Diseases:** cholangitis (MONDO:0004789)

## Full-text entities

- **Diseases:** intrahepatic bile duct dilatation (MESH:C531647), common bile duct stones (MESH:D042882), biliary lesions (MESH:D001660), POC (MESH:D002761), death (MESH:D003643), Bile duct lesions (MESH:D001649)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11179028/full.md

---
Source: https://tomesphere.com/paper/PMC11179028